Skip to main content
Genscript Biotech Corporation (HKG:1548)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
11.91
+0.23 (1.97%)
Mar 10, 2026, 2:04 PM HKT

Genscript Biotech Revenue

Genscript Biotech had revenue of $518.77M USD in the half year ending June 30, 2025, with 32.57% growth. This brings the company's revenue in the last twelve months to $828.10M, up 63.20% year-over-year. In the year 2024, Genscript Biotech had annual revenue of $594.49M with 6.07% growth.

Revenue (ttm)
$828.10M
Revenue Growth
+63.20%
P/S Ratio
3.93
Revenue / Employee
$143.54K
Employees
5,769
Market Cap
25.54B HKD

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024594.49M34.01M6.07%
Dec 31, 2023560.48M-65.22M-10.42%
Dec 31, 2022625.70M135.60M27.67%
Dec 31, 2021490.10M99.25M25.39%
Dec 31, 2020390.85M117.49M42.98%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
InnoCare Pharma 1.56B
Duality Biotherapeutics 2.38B
PegBio -4.25M
Shanghai Junshi Biosciences 2.78B
Biocytogen Pharmaceuticals (Beijing) 1.53B
Shanghai Henlius Biotech 6.35B
Zai Lab 3.58B
Ascentage Pharma Group International 428.02M
Revenue Rankings

Genscript Biotech News

More News